
Justin Wahlstrom MD
Pediatric Hematologic Oncology
Physician
Join to view full profile
1825 4th StSan Francisco, CA 94143
Phone+1 415-476-1000
Dr. Wahlstrom is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2010 - 2012
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2008 - 2010
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2004 - 2008
Vanderbilt University School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2010 - 2026
NY State Medical License 2006 - 2012
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
Publications & Presentations
PubMed
- 39 citationsIbrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study.David Bernard Miklos, Mohammad Abu Zaid, Julian P Cooney, Jörn C Albring, Mary Flowers
Journal of Clinical Oncology. 2023-04-01 - 29 citationsIbrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study.Paul A Carpenter, Hyoung Jin Kang, Keon Hee Yoo, Marco Zecca, Bin Cho
Transplantation and Cellular Therapy. 2022-11-01 - Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHDDanielle E. Arnold, Rofida Nofal, Connor Wakefield, Kai Lehmberg, Katharina Wustrau
Journal of Clinical Immunology. 2021-09-29
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: